Developmental exposure to environmental factors has been linked to obesity risk later in life. Nuclear receptors are molecular sensors that play critical roles during development, and as such are prime candidates to explain the developmental programming of disease risk by environmental chemicals. We have previously characterized the ‘obesogen’ tributyltin (TBT), which activates the nuclear receptors Peroxisome proliferator-activated receptor γ (PPARγ) and Retinoid X receptor (RXR) to increase adiposity in mice exposed in utero. Mesenchymal stem cells (MSCs) from these mice are biased towards the adipose lineage at the expense of the osteoblast lineage, and MSCs exposed to TBT in vitro are shunted towards the adipose fate in a PPARγ-dependent fashion. To address where in the adipogenic cascade TBT acts, we developed an in vitro ‘commitment assay’ that permitted us to distinguish early commitment to the adipose lineage from subsequent differentiation. TBT and RXR activators (rexinoids) had potent effects in committing MSCs to the adipose lineage, whereas the strong PPARγ activator rosiglitazone (ROSI) was inactive. We show that activation of RXR is sufficient for adipogenic commitment and that rexinoids act through RXR to alter the transcriptome in a manner favoring adipogenic commitment. RXR activation alters expression of Enhancer of zeste 2 (EZH2) and modifies genome-wide histone 3 lysine 27 trimethylation (H3K27me3) in promoting adipose commitment and programming subsequent differentiation. These data offer novel insights into the roles of RXR and EZH2 in MSC lineage specification and shed new light on how endocrine disrupting chemicals such as TBT can reprogram stem cell fate.
Early life exposure to endocrine-disrupting chemicals (EDCs) is an emerging risk factor for the development of obesity and diabetes later in life. We previously showed that prenatal exposure to the EDC tributyltin (TBT) results in increased adiposity in the offspring. These effects linger into adulthood and are propagated through successive generations. TBT activates two nuclear receptors, the peroxisome proliferator–activated receptor (PPAR) γ and its heterodimeric partner retinoid X receptor (RXR), that promote adipogenesis in vivo and in vitro. We recently employed a mesenchymal stem cell (MSC) model to show that TBT promotes adipose lineage commitment by activating RXR, not PPARγ. This led us to consider the functional consequences of PPARγ vs RXR activation in developing adipocytes. We used a transcriptomal approach to characterize genome-wide differences in MSCs differentiated with the PPARγ agonist rosiglitazone (ROSI) or TBT. Pathway analysis suggested functional deficits in TBT-treated cells. We then compared adipocytes differentiated with ROSI, TBT, or a pure RXR agonist IRX4204 (4204). Our data show that RXR activators (“rexinoids,” 4204 and TBT) attenuate glucose uptake, blunt expression of the antidiabetic hormone adiponectin, and fail to downregulate proinflammatory and profibrotic transcripts, as does ROSI. Finally, 4204 and TBT treatment results in an inability to induce markers of adipocyte browning, in part due to sustained interferon signaling. Taken together, these data implicate rexinoids in the development of dysfunctional white adipose tissue that could potentially exacerbate obesity and/or diabetes risk in vivo. These data warrant further screening and characterization of EDCs that activate RXR.
10 September 2024 in Seminars in Arthroplasty: JSES
Background: This study evaluated the efficacy of woodcast (WC) versus thermoplastic (TP) splints for postoperative immobilization following carpometacarpal (CMC) joint suspensionplasty. The hypothesis was that WC splints would provide improved efficacy and compliance compared with TP splints, while also reducing waste generation. Methods: A prospective, randomized controlled trial enrolled 26 patients, all older than 18 years old, undergoing CMC joint suspensionplasty. Participants were randomized to receive postoperative splinting with either a WC or TP splint. Exclusion criteria included additional procedures on the same arm or surgeon-determined unsuitability. Outcomes assessed included patient comfort, compliance, satisfaction, complication rates, and quantity of waste material generated by each splint type. Results: The TP group demonstrated higher splint compliance and fewer splint-related complications than the WC group. Both groups reported similar satisfaction concerning their splints and overall treatment. However, the WC group generated significantly less waste (3.14 ± 1.38 g) compared with the TP group (20.88 ± 9.64 g), an 85% reduction. Functional outcome scores (Quick Disabilities of Arm, Shoulder, and Hand, Patient-Rated Wrist Evaluation, visual analog scale) were similar between groups at all time points. Conclusions: Thermoplastic splinting resulted in greater compliance and fewer complications but generated substantially more waste than WC splinting. As both splint types yielded comparable functional outcomes, the choice of splinting material should account for therapist expertise and health care waste considerations. The findings support exploring alternative biodegradable splint materials that support waste management without compromising patient care. Randomized Controlled Trial: ClinicalTrials.gov ID: NCT06876350